Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...

Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue ...

About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

Called the photovoltaic retina implant microarray (PRIMA), the small system uses a subretinal ... The researchers said they ...

Michael O'Connell, Chief Analytics Officer at Spotfire, on his journey to technology leadership in energy management ...

Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.

This report provides a comprehensive analysis of the next-generation proteomics market, highlighting key trends, drivers and ...

The treatment involves inserting a tiny implant thinner than human hair under the retina. Patients then have to wear glasses ...

Find out how asparagus and vanilla orchids demonstrate the importance of cell walls in plant survival and adaptability.